The Japanese drugmaker said that interim results from the 530-patient VISIONARY study showed that sibeprenlimab achieved a ...

To learn more about the true value of AI and GenAI, pharmaphorum spoke with Sudip Chakraborty, Principal and Head of AI/GenAI ...

In 2018, the EEA accounted for 18% and China made up around 9%, with the massive increase in the latter in a few short years ...

AstraZeneca and Ionis are set fair for EU approval of Wainzua, their treatment for polyneuropathy associated with ...

Earlier this month, Sanofi revealed talks were ongoing with CD&R, and has now confirmed the negotiations could result in the ...

Boston-based Seaport said the money would support a pipeline of improved neuropsychiatric drug candidates led by SPT-300, an ...